PR Newswire - WuXi Vaccines' Drug Substance Facility Receives Br...
SUZHOU, China, May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today...
Read More

ภาษาไทย
English